v3.26.1
Segment Reporting (Details)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
USD ($)
Mar. 31, 2026
USD ($)
Jun. 30, 2025
USD ($)
Jun. 30, 2026
USD ($)
segment
Jun. 30, 2025
USD ($)
Segment information          
Revenue $ 559     $ 797  
Revenue 0   $ 0 0 $ 0
Cost of product sales 32   0 46 0
Share-based compensation expense 1,338   1,308 2,620 2,659
Interest income (1,741)   (516) (3,473) (1,213)
Royalty financing interest expense 3,705 $ 3,133      
Note payable interest expense 4,725   951 8,860 1,886
Net loss (28,614)   (12,966) $ (54,680) (33,727)
Number of operating segments | segment       1  
Number of reportable segments | segment       1  
Single reporting          
Segment information          
Revenue 559     $ 797  
Cost of product sales 32     46  
Research and development, net of tax credits, excluding share-based compensation 3,134   3,302 5,984 7,850
General and administrative, excluding share-based compensation 5,055   3,036 9,241 7,465
Commercial, excluding share-based compensation 14,540   3,310 28,308 11,335
Medical affairs, excluding share-based compensation 2,090   1,575 3,891 3,745
Share-based compensation expense 1,338   1,308 2,620 2,659
Interest income (1,741)   (516) (3,473) (1,213)
Royalty financing interest expense 3,705     6,838  
Note payable interest expense 1,020   951 2,022 1,886
Net loss $ (28,614)   $ (12,966) $ (54,680) $ (33,727)